{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:01:08Z","timestamp":1767171668617,"version":"build-2238731810"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>COVID-19 induced cytokine storm is a well-documented phenomena that contributes significantly in the disease\u2019s evolution and prognosis. Therefore, therapies such as therapeutic plasma exchange, constitute a mainstay of therapeutic management especially for critically-ill patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a monocentric retrospective cohort study in the Resuscitation Department of the Mohammed VI University Hospital of Oujda-Morocco, to evaluate the efficiency of therapeutic plasma exchange on critically-ill COVID-19 patients over a 6 months period.<\/jats:p>\n                    <jats:p>We divided our patients into two groups: patients who received TPE (Therapeutic Plasma Exchange) sessions (TPE group) and patients who only benefited from the standard protocol treatment (non TPE group).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study included a total of 165 patients, 34.5% of which benefited from TPE sessions.<\/jats:p>\n                    <jats:p>We observed an improvement of oxygenation parameters (SpO2 and PaO2\/FiO2 ratio) and a progressive respiratory weaning, as well as a significant decrease of biomarkers indicative of inflammation (lymphocyte count, CRP (C Reactive Protein), IL-6, Ferritin) and coagulopathy (d-dimers, fibrinogen) in the TPE group after 5 consecutive TPE sessions.<\/jats:p>\n                    <jats:p>In comparison with the non-TPE group, The TPE-group patients had a shorter ICU (Intensive Care Unit) length of stay, required less frequently mechanical ventilation, and we more likely to be extubated. Furthermore, the TPE group had a lower mortality rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Multiple studies have reported the safety and efficiency of therapeutic plasma exchange in the COVID-19 induced cytokine storm. Given the urgent character of the pandemic at the time, each center followed its own protocol in implementing plasma exchange.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Similar to the results reported in the literature, our study reports positive results after using TPE specifically in terms of respiratory weaning and an improvement of the cytokine storm biomarkers, and more importantly a lower mortality rate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08816-6","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T09:01:39Z","timestamp":1700902899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic plasma exchange in the treatment of COVID-19 induced cytokine storm: the first Moroccan experience"],"prefix":"10.1186","volume":"23","author":[{"given":"Mohamed Zakaria","family":"Bouayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilyass","family":"Laaribi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iliass","family":"Benaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmae","family":"Yeznasni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Berrajaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younes","family":"Oujidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houssam","family":"Bkiyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naima","family":"Abda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brahim","family":"Housni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,25]]},"reference":[{"key":"8816_CR1","unstructured":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https:\/\/coronavirus.jhu.edu\/map.html."},{"issue":"7","key":"8816_CR2","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2666-5247(20)30144-0","volume":"1","author":"B Schurink","year":"2020","unstructured":"Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1(7):e290\u20139.","journal-title":"Lancet Microbe"},{"key":"8816_CR3","doi-asserted-by":"publisher","first-page":"101545","DOI":"10.1016\/j.smim.2021.101545","volume":"55","author":"MW Mather","year":"2021","unstructured":"Mather MW, Jardine L, Talks B, Gardner L, Haniffa M. Complexity of immune responses in COVID-19. Semin Immunol. 2021;55:101545.\u00a0Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1044532321000762.","journal-title":"Semin Immunol."},{"issue":"1","key":"8816_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","volume":"19","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb S, HosseiniyanKhatibi SM, Hejazi MS, Tarhriz V, Farjami A, GhasemianSorbeni F, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19(1):92. https:\/\/doi.org\/10.1186\/s12985-022-01814-1.","journal-title":"Virol J"},{"key":"8816_CR5","doi-asserted-by":"crossref","unstructured":"Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 2020;11. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2020.01446.","DOI":"10.3389\/fimmu.2020.01446"},{"issue":"8","key":"8816_CR6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3390\/v13081484","volume":"13","author":"\u0141J Krzych","year":"2021","unstructured":"Krzych \u0141J, Putowski Z, Czok M, Hofman M. What is the role of therapeutic plasma exchange as an adjunctive treatment in severe COVID-19: a systematic review. Viruses. 2021;13(8):1484.\u00a0Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34452349.","journal-title":"Viruses."},{"issue":"9","key":"8816_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/0885066620940259","volume":"35","author":"S Tabibi","year":"2020","unstructured":"Tabibi S, Tabibi T, Conic RRZ, Banisaeed N, Streiff MB. Therapeutic plasma exchange: a potential management strategy for critically Ill COVID-19 patients. J Intensive Care Med. 2020;35(9):827\u201335.\u00a0Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32666875.","journal-title":"J Intensive Care Med."},{"issue":"2","key":"8816_CR8","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/S2666-5247(20)30223-8","volume":"2","author":"LYC Chen","year":"2021","unstructured":"Chen LYC, Quach TTT. COVID-19 cytokine storm syndrome: a threshold concept. Lancet Microbe. 2021;2(2):e49-50. https:\/\/doi.org\/10.1016\/S2666-5247(20)30223-8.","journal-title":"Lancet Microbe"},{"issue":"23","key":"8816_CR9","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255\u201373. https:\/\/doi.org\/10.1056\/NEJMra2026131.","journal-title":"N Engl J Med"},{"key":"8816_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","volume":"95","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z, et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis. 2020;95:332\u20139.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"8816_CR11","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636\u201343.","journal-title":"Nat Med"},{"issue":"6508","key":"8816_CR12","doi-asserted-by":"publisher","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","volume":"369","author":"D Mathew","year":"2020","unstructured":"Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):eabc8511.","journal-title":"Science."},{"issue":"1","key":"8816_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/annrheumdis-2020-218323","volume":"80","author":"R Caricchio","year":"2021","unstructured":"Caricchio R, Gallucci M, Dass C, Zhang X, Gallucci S, Fleece D, et al. Preliminary predictive criteria for COVID-19 cytokine storm. Mishkin A, Abbas A, Pathak AS, Rastogi A, Diamond A, Satti A, et al., editors. Ann Rheum Dis. 2021;80(1):88\u201395.\u00a0Available from: https:\/\/ard.bmj.com\/content\/80\/1\/88.","journal-title":"Ann Rheum Dis."},{"issue":"10","key":"8816_CR14","doi-asserted-by":"publisher","first-page":"e052777","DOI":"10.1136\/bmjopen-2021-052777","volume":"11","author":"Y Mahamat-Saleh","year":"2021","unstructured":"Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open. 2021;11(10):e052777.","journal-title":"BMJ Open"},{"key":"8816_CR15","doi-asserted-by":"crossref","unstructured":"Mehta P, McAuley DF, Brown M et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u2013134.","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"8816_CR16","doi-asserted-by":"crossref","unstructured":"Castillo B, Dasgupta A, Klein K, Tint H, Wahed A. Chapter 6 - Apheresis. In: Castillo B, Dasgupta A, Klein K, Tint H, Wahed ABT-TM for P, editors. Elsevier; 2018. p. 113\u201324. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978012814313100006X.","DOI":"10.1016\/B978-0-12-814313-1.00006-X"},{"issue":"1","key":"8816_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13054-020-03215-8","volume":"24","author":"B Gucyetmez","year":"2020","unstructured":"Gucyetmez B, Atalan HK, Sertdemir I, Cakir U, Telci L, Ogan A, et al. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study. Crit Care. 2020;24(1):492. https:\/\/doi.org\/10.1186\/s13054-020-03215-8.","journal-title":"Crit Care"},{"issue":"5","key":"8816_CR18","doi-asserted-by":"publisher","first-page":"106334","DOI":"10.1016\/j.ijantimicag.2021.106334","volume":"57","author":"F Faqihi","year":"2021","unstructured":"Faqihi F, Alharthy A, Abdulaziz S, Balhamar A, Alomari A, AlAseri Z, et al. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial. Int J Antimicrob Agents. 2021;57(5):106334.\u00a0Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0924857921000716.","journal-title":"Int J Antimicrob Agents."},{"issue":"4","key":"8816_CR19","doi-asserted-by":"publisher","first-page":"103433","DOI":"10.1016\/j.transci.2022.103433","volume":"61","author":"M Beraud","year":"2022","unstructured":"Beraud M, Hashami SAl, Lozano M, Bah A, Keith P. Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome. Transfus Apher Sci. 2022;61(4):103433.\u00a0Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1473050222001057.","journal-title":"Transfus Apher Sci."},{"issue":"6","key":"8816_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41584-021-00608-z","volume":"17","author":"M Ramos-Casals","year":"2021","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol. 2021;17(6):315\u201332. https:\/\/doi.org\/10.1038\/s41584-021-00608-z.","journal-title":"Nat Rev Rheumatol"},{"issue":"10223","key":"8816_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497\u2013506.\u00a0Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673620301835.","journal-title":"China. Lancet."},{"issue":"7","key":"8816_CR22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/vox.13067","volume":"116","author":"GK Patidar","year":"2021","unstructured":"Patidar GK, Land KJ, Vrielink H, Rahimi-Levene N, Dann EJ, Al-Humaidan H, et al. Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices. Vox Sang. 2021;116(7):798\u2013807.","journal-title":"Vox Sang"}],"updated-by":[{"DOI":"10.1186\/s12879-023-08855-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08816-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T14:02:44Z","timestamp":1702044164000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08816-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,25]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8816"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08816-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,25]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-023-08855-z","URL":"https:\/\/doi.org\/10.1186\/s12879-023-08855-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the World Medical Association's Code of Ethics (Declaration of Helsinki) for medical research involving human subjects (17) and was granted approval by the Ethics Committee for Biomedical Research of Oujda (N\u00b0 017\/20).Written informed consent was obtained from each participant or legal proxy.This study is registered in the Research Registry database under N\u00b0: 8448.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"829"}}